Ranolazine tablet bulk supplier for pharma manufacturers

Ranolazine Tablet 500 mg and 1000 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 500 mg and 1000 mg

Reference Brands: Ranexa(US & EU)

Ranolazine inhibits late sodium current in cardiac cells, reducing calcium overload and improving myocardial efficiency. It decreases angina episodes, enhances exercise tolerance, and reduces oxygen demand. Benefits include better symptom control, improved cardiac function, and increased quality of life for patients with chronic angina.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Ranolazine tablets, marketed as Ranexa, are approved in the US by the FDA and in the EU via EMA for the treatment of chronic angina. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe medication use, and global availability, helping millions manage angina and improve quality of life worldwide effectively.

Ranolazine Tablet — third party manufacturing & bulk supply

Ranolazine Tablet 500 mg and 1000 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ranolazine Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ranolazine Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ranolazine Tablet →

Back to Listing

Frequently Asked Questions

Ranolazine tablet is listed as Tablet in 500 mg and 1000 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ranolazine tablet is referenced against Ranexa(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.